Loading organizations...
Loading organizations...
Biopharmaceutical company developing CNS therapeutics via gut-brain axis.
Axial Biotherapeutics has raised $91.4M across 4 funding rounds.
Axial Biotherapeutics has raised $91.4M in total across 4 funding rounds.
Axial Biotherapeutics has raised $91.4M in total across 4 funding rounds.
Axial Biotherapeutics's investors include Sarah Meibusch, Makoto Ohori, Autism Impact Fund, Corundum Systems Biology, Domain Associates, Longwood Fund, Nora Frey, Taiho Ventures, Sakae Asanuma, Isabelle de Cremoux, Heritage Medical Systems, Jim Blair.
Axial Biotherapeutics has raised $91.4M across 4 funding rounds. Most recently, it raised $37.3M Series C in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 13, 2021 | $37.3M Series C | Sarah Meibusch, Makoto Ohori | Autism Impact Fund, Corundum Systems Biology, Domain Associates, Longwood Fund, Nora Frey, Taiho Ventures |
| Jun 20, 2019 | $10.0M Series B Extension | Sakae Asanuma | |
| Feb 27, 2019 | $25.0M Series B | Isabelle de Cremoux | Domain Associates, Heritage Medical Systems, Longwood Fund |
| Nov 30, 2016 | $19.1M Series A | Jim Blair, Michelle Detwiler | Heritage Medical Systems, Kairos Ventures |